Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
MRUS
Stock Latest News
Ratings
Cautious Optimism for Merus’s Petosemtamab in mCRC Amidst Limited Data, Hold Rating Maintained
3d ago
MRUS
Premium
The Fly
Oppenheimer positive on CytomX after Merus colon cancer data
3d ago
CTMX
MRUS
Premium
Ratings
Hold Rating on Merus’s Petosemtamab: Awaiting More Data for Colorectal Cancer Efficacy
3d ago
MRUS
Premium
The Fly
Merus announces initial interim data from phase 2 trial of petosemtamab
4d ago
MRUS
Premium
Ratings
Cautious Optimism: Hold Rating on Merus Amid Anticipation of Phase II Data Presentation and Genmab Acquisition
4d ago
MRUS
Premium
The Fly
Genmab price target raised to $49 from $46 at Truist
12d ago
GMAB
MRUS
Premium
The Fly
Merus downgraded to Market Perform from Outperform at Leerink
12d ago
MRUS
Premium
The Fly
Unusually active option classes on open October 2nd
15d ago
VG
CAN
Premium
Ratings
Balanced Hold Rating Amid Genmab’s Acquisition of Merus and Anticipated CRC Data
18d ago
MRUS
Premium
Ratings
Hold Rating on Genmab’s Acquisition of Merus Reflects Fair Valuation and Limited Upside Potential
18d ago
MRUS
Premium
The Fly
Merus downgraded to Neutral from Buy at UBS
18d ago
MRUS
Premium
The Fly
Merus downgraded to Market Perform from Outperform at BMO Capital
18d ago
MRUS
Premium
The Fly
Merus downgraded to Equal Weight from Overweight at Barclays
18d ago
MRUS
Premium
The Fly
Merus downgraded to Market Perform from Outperform at LifeSci Capital
18d ago
MRUS
Premium
Ratings
Balanced Hold Rating on Genmab’s Acquisition of Merus Amid Valuation and Strategic Fit Concerns
18d ago
MRUS
Premium
The Fly
Merus downgraded to Neutral from Buy at Guggenheim
18d ago
MRUS
Premium
Ratings
Hold Rating Given to Merus Amid Genmab Acquisition Reflecting Full Stock Valuation and Strategic Asset Integration
18d ago
MRUS
Premium
The Fly
Merus downgraded to Neutral from Buy at H.C. Wainwright
18d ago
MRUS
Premium
The Fly
Genmab price target raised to $34 from $32 at Leerink
18d ago
GMAB
MRUS
Premium
The Fly
Merus rises 36.3%
18d ago
MRUS
Premium
The Fly
Merus downgraded to Hold from Buy at Canaccord
18d ago
MRUS
Premium
The Fly
Merus downgraded to Market Perform from Outperform at William Blair
18d ago
MRUS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
